Home » Topics » BioWorld Science, Cancer

BioWorld Science, Cancer
RSS

BASF prepares dolastatin derivatives

Feb. 14, 1997

Retinoid series for cancer

Feb. 14, 1997

Idec acquires rights to anticancer agent

Feb. 13, 1997

Basal lamina-based drugs offer promise for tumor metastasis

Feb. 13, 1997

Supplemental NDA filed for Photofrin

Feb. 13, 1997

Orphan Medical expands clinical trials of Busulfanex

Feb. 13, 1997

Sugen reports modulators of tyrosine signal transduction

Feb. 13, 1997

Anticancer agents from Takeda

Feb. 13, 1997

Antineoplastic retinoid compounds disclosed

Feb. 12, 1997

U.K. launch for SKB anticancer treatment

Feb. 11, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 18, 2026.
Precision psychiatry beyond, or before, biomarkers
BioWorld
There is broad agreement that psychiatric diagnoses in their current form are not reflective of any underlying biology, and that this is one of the things...
Keros reports beneficial effects of RKER-065 in ALS model
BioWorld Science
Keros Therapeutics Inc. has presented data regarding their activin receptor ligand trap, RKER-065, for the inhibition of the activin/myostatin signaling axis.
News in brief
BioWorld Asia
BioWorld Asia briefs for March 17, 2026
First-in-class POLG activator restores mtDNA across mutations
BioWorld Science
Researchers from Pretzel Therapeutics Inc. presented preclinical data of PX-578, a first-in-class POLG activator aimed at restoring mtDNA replication and...